St. Louis Park, MN, United States of America

Emily Rolfes Meyering

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 6.1

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Emily Rolfes Meyering: Pioneering Solutions in Biologic Fluid Treatment

Introduction: Emily Rolfes Meyering, an inventive mind based in St. Louis Park, MN, has made significant contributions to the field of cerebrospinal fluid (CSF) treatments. With a remarkable portfolio of six patents, she has demonstrated her exceptional capabilities in developing systems and methods that enhance the handling and treatment of biologic fluids.

Latest Patents: Among her latest innovations, two patents stand out. The first is for "Systems and methods for the conditioning of cerebrospinal fluid." This patent describes various embodiments that can filter cerebrospinal fluid from human or animal subjects, as well as heat or cool it to target temperatures. Additionally, it encompasses light treatment applications, cell separation based on dielectric properties, and optimization of parameters like flow rate during operation.

The second noteworthy patent is for the "Tangential flow filter system for the filtration of materials from biologic fluids." This invention focuses on the filtration of CSF, utilizing a tangential flow filter to separate the fluid into permeate and retentate, which are subsequently treated and returned to the subject. The system also allows for modifications of operational parameters such as flow rate and waste rate.

Career Highlights: Emily is associated with Minnetronix, Inc., a company known for its commitment to innovative medical technologies. Her work centers on improving the treatment processes for biologic fluids, thereby making significant strides in healthcare applications.

Collaborations: Throughout her career, Emily has worked alongside talented individuals such as Blake A. Hedstrom and Aaron R. McCabe. These collaborations have undoubtedly enriched her research and innovation efforts, contributing to the advancement of medical technologies.

Conclusion: Emily Rolfes Meyering exemplifies the spirit of innovation within the medical field. Her patents not only reflect her dedication to improving patient outcomes but also highlight the potential for further advancements in the treatment of biologic fluids. As she continues to push the boundaries of science and technology, her contributions will inspire future inventors and researchers in various fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…